Malignant hyperthermia: a pharmacogenetic disorder

Identification and Biochemical Characterization of a Novel Ryanodine Receptor Gene Mutation Associated with Malignant Hyperthermia

(2009) Ayuk A. Anderson et al.   ANESTHESIOLOGY

Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP

(2008) Paula L. Diaz-Sylvester et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Personal recollections on the discovery of the ryanodine receptors of muscle

(2008) Sidney Fleischer   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

SRP-27 is a novel component of the supramolecular signalling complex involved in skeletal muscle excitation–contraction coupling

(2008) Christophe Bleunven et al.   BIOCHEMICAL JOURNAL

TRPC3-interacting triadic proteins in skeletal muscle

(2008) Jin Seok Woo et al.   BIOCHEMICAL JOURNAL

The α1SIII-IV Loop Influences 1,4-Dihydropyridine Receptor Gating but Is Not Directly Involved in Excitation-Contraction Coupling Interactions with the Type 1 Ryanodine Receptor

(2008) Roger A. Bannister et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Enhanced Excitation-Coupled Calcium Entry in Myotubes Expressing Malignant Hyperthermia Mutation R163C Is Attenuated by Dantrolene

(2008) G. Cherednichenko et al.   MOLECULAR PHARMACOLOGY

STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle

(2008) Jonathan Stiber et al.   NATURE CELL BIOLOGY

Remodeling of ryanodine receptor complex causes "leaky" channels: A molecular mechanism for decreased exercise capacity

(2008) A. M. Bellinger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Distinct mechanisms for dysfunctions of mutated ryanodine receptor isoforms

(2007) Yasuo Ogawa   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS